V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003149 | 210008819 | 1.71 | 49 | Adjuvant (A) | 2016-06-28 | 2016-07-11 | Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101333903 |
| 210003151 | 210008821 | 1.58 | 74.4 | Neo-adjuvant (N) | 2018-09-04 | 2018-09-26 | Letrozole + Palbociclib | 02 | N | PALBOCICLIB | 100910185 |
| 210003152 | 210008822 | 1.5 | 67 | null | 2019-08-03 | 2019-09-07 | null | null | null | FEC + DOCETAXEL | 101399222 |
| 210003153 | 210008823 | 1.67 | 98.3 | Neo-adjuvant (N) | 2020-01-05 | 2020-01-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101127410 |
| 210003154 | 210008824 | 1.72 | 56.8 | null | null | 2020-09-23 | Capecitabine | N | null | CAPECITABINE | 101747755 |
| 210003156 | 210008825 | 1.68 | 71.95 | Neo-adjuvant (N) | 2021-05-30 | 2021-05-30 | Capecitabine | 02 | N | CAPECITABINE | 100730190 |
| 210003157 | 210008826 | 1.67 | 76.4 | Neo-adjuvant (N) | 2016-04-13 | 2016-04-23 | Eribulin | 02 | N | ERIBULIN | 100040142 |
| 210003161 | 210008829 | 1.65 | 92.45 | null | 2022-01-21 | 2022-02-18 | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 02 | null | CARBOPLATIN + DOCETAXEL | 100345016 |
| 210003162 | 210008830 | 1.59 | 73.6 | Adjuvant (A) | 2016-05-30 | 2016-07-01 | Capecitabine | 02 | N | CAPECITABINE | 100331511 |
| 210003163 | 210008831 | 1.69 | 97.2 | null | 2016-03-28 | 2016-04-05 | Carboplatin + Docetaxel | 02 | null | PALBOCICLIB | 100481283 |
| 210003164 | 210008832 | null | 86.4 | null | 2017-05-24 | 2017-05-25 | NAB PACLITAXEL | 02 | null | SACITUZUMAB GOVITECAN | 100322804 |
| 210003166 | 210008833 | 1.63 | 69 | null | 2021-01-01 | 2021-03-06 | ABEMACICLIB + FULVESTRANT | 02 | null | LETROZOLE + PALBOCICLIB | 100079108 |
| 210003167 | 210008834 | 1.66 | 85.4 | Adjuvant (A) | 2019-06-27 | 2019-07-02 | null | 02 | N | NAB-PACLITAXEL | 100092492 |
| 210003169 | 210008836 | 0 | 63.5 | Palliative (P) | 2016-08-22 | 2016-09-19 | EC + DOCETAXEL | 02 | N | NAB-PACLITAXEL | 100296691 |
| 210003170 | 210008837 | null | 72.8 | Palliative (P) | 2019-05-03 | 2019-05-05 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101062258 |
| 210003172 | 210008838 | 1.51 | 72.6 | Adjuvant (A) | 2018-06-24 | 2018-09-11 | Capecitabine | 02 | N | CAPECITABINE | 100299561 |
| 210003173 | 210008839 | 1.62 | 117.4 | Palliative (P) | 2020-01-20 | 2020-04-28 | CMF | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101675931 |
| 210003175 | 210008840 | null | 103 | Adjuvant (A) | 2018-07-19 | 2018-07-19 | Fulvestrant + Palbociclib | 02 | N | PACLITAXEL + TRASTUZUMAB | 101065228 |
| 210003177 | 210008841 | 1.66 | 68.8 | null | 2018-09-13 | 2019-02-18 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100715959 |
| 210003179 | 210008842 | 1.61 | 72.9 | Palliative (P) | null | 2016-06-21 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100324559 |
| 210003181 | 210008844 | 1.48 | 63.5 | Adjuvant (A) | null | 2020-10-23 | ATEZOLIZUMAB + NAB PACLITAXEL | N | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100302192 |
| 210003182 | 210008845 | null | 49 | null | 2018-12-06 | 2018-12-10 | null | 02 | null | TRIAL UNSPECIFIED | 100777017 |
| 210003184 | 210008846 | 1.75 | 77.4 | Adjuvant (A) | null | 2019-11-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100356887 |
| 210003189 | 210008849 | 1.5 | 84.1 | null | 2018-10-15 | 2018-10-21 | Capecitabine | null | null | CAPECITABINE | 100328559 |
| 210003190 | 210008850 | 1.75 | 0 | null | 2018-08-02 | 2018-12-19 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100503820 |
| 210003193 | 210008851 | null | 77 | Palliative (P) | 2018-05-19 | 2018-08-27 | Capecitabine | N | N | CAPECITABINE | 101684009 |
| 210003194 | 210008852 | 1.65 | 56.7 | Neo-adjuvant (N) | 2019-03-22 | 2019-05-08 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101493971 |
| 210003195 | 210008853 | 1.77 | 65.4 | Neo-adjuvant (N) | 2018-01-17 | 2018-02-21 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101518937 |
| 210003196 | 210008854 | null | null | null | 2016-08-30 | 2016-09-08 | ROSCO Trial | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100632279 |
| 210003199 | 210008856 | null | null | null | null | 2017-06-17 | Trial Unspecified | 02 | null | EPIRUBICIN | 100272287 |
| 210003201 | 210008857 | 1.47 | 94.4 | null | 2018-01-05 | 2018-03-21 | null | N | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100423444 |
| 210003203 | 210008858 | 1.52 | 53.9 | null | 2021-03-19 | 2021-04-09 | Capecitabine | 02 | null | CAPECITABINE | 101584040 |
| 210003207 | 210008860 | 1.75 | 79.2 | null | 2018-01-30 | 2018-01-31 | Trial Unspecified | 02 | null | PALBOCICLIB | 101081006 |
| 210003209 | 210008861 | 1.54 | 84.1 | Palliative (P) | null | 2019-11-29 | null | 02 | N | FULVESTRANT + RIBOCICLIB | 101497595 |
| 210003213 | 210008863 | 1.57 | 71.5 | Adjuvant (A) | 2021-08-17 | 2021-10-20 | Capecitabine | null | N | CAPECITABINE | 101567210 |
| 210003214 | 210008864 | 1.58 | 81 | Neo-adjuvant (N) | 2021-06-01 | 2021-06-02 | Capecitabine | 02 | N | CAPECITABINE | 100508829 |
| 210003218 | 210008867 | 1.66 | 131 | Palliative (P) | 2017-12-25 | 2018-01-17 | null | 02 | N | FULVESTRANT + PALBOCICLIB | 101162900 |
| 210003219 | 210008868 | 1.61 | 77.5 | Palliative (P) | 2016-10-16 | 2018-02-21 | Capecitabine | 02 | N | CAPECITABINE | 101635608 |
| 210003221 | 210008870 | 1.62 | 62.4 | Palliative (P) | null | 2017-08-17 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100633312 |
| 210003222 | 210008871 | 1.76 | 71.5 | Adjuvant (A) | 2021-08-14 | 2021-09-05 | FEC | 02 | N | ABEMACICLIB | 100507774 |
| 210003223 | 210008872 | 1.55 | 58.7 | null | 2017-05-02 | 2017-05-10 | Neratinib | null | null | NERATINIB | 101712169 |
| 210003224 | 210008873 | 1.55 | 72.7 | Palliative (P) | 2017-05-05 | 2017-05-13 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101552581 |
| 210003225 | 210008874 | 1.69 | 77.6 | Adjuvant (A) | 2018-02-21 | 2018-02-22 | Capecitabine | 02 | N | CAPECITABINE | 101114576 |
| 210003226 | 210008875 | 1.77 | 87 | Curative (C) | 2019-08-18 | 2019-11-04 | Paclitaxel albumin (Abraxane) 21day | null | N | EPIRUBICIN | 100456723 |
| 210003228 | 210008876 | 1.58 | 63.85 | null | 2018-03-23 | 2018-04-05 | null | 02 | null | EPIRUBICIN | 101095975 |
| 210003230 | 210008877 | null | 78.3 | Adjuvant (A) | 2016-08-01 | 2016-08-02 | Carboplatin AUC 2 - 5 | N | Y | CARBOPLATIN | 100654224 |
| 210003240 | 210008880 | 1.61 | 71.4 | Neo-adjuvant (N) | 2019-05-10 | 2019-05-13 | null | null | N | CARBOPLATIN + PACLITAXEL | 101309644 |
| 210003260 | 210008892 | 1.69 | 117.8 | Adjuvant (A) | null | 2017-02-12 | null | 02 | N | FEC | 101642636 |
| 210003261 | 210008893 | 1.69 | 129 | Palliative (P) | 2018-04-16 | 2018-09-02 | Eribulin | 02 | N | ERIBULIN | 100518616 |
| 210003263 | 210008894 | 1.69 | 47 | null | 2018-09-15 | 2018-09-22 | null | 02 | null | TCH | 101824256 |